TARGETTI, MATTIA
 Distribuzione geografica
Continente #
EU - Europa 739
NA - Nord America 676
AS - Asia 225
AF - Africa 5
SA - Sud America 1
Totale 1.646
Nazione #
US - Stati Uniti d'America 674
PL - Polonia 183
RU - Federazione Russa 166
IT - Italia 153
IE - Irlanda 94
SE - Svezia 90
HK - Hong Kong 55
SG - Singapore 51
CN - Cina 48
IN - India 30
JO - Giordania 25
VN - Vietnam 10
GB - Regno Unito 9
CH - Svizzera 7
DK - Danimarca 7
FI - Finlandia 6
UA - Ucraina 5
ES - Italia 4
FR - Francia 4
RO - Romania 4
BE - Belgio 3
KR - Corea 3
CA - Canada 2
CI - Costa d'Avorio 2
DE - Germania 2
MA - Marocco 2
BR - Brasile 1
GE - Georgia 1
NL - Olanda 1
PT - Portogallo 1
SC - Seychelles 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
Totale 1.646
Città #
Warsaw 180
Dublin 94
Fairfield 86
Chandler 63
Ashburn 51
Seattle 46
Ann Arbor 39
Hong Kong 35
Singapore 35
Woodbridge 34
Houston 33
Wilmington 33
Cambridge 30
Lawrence 29
Altamura 28
Florence 28
Mumbai 28
Princeton 18
Scandicci 17
Shanghai 17
Beijing 16
Boston 16
Buffalo 12
New York 12
Boardman 9
Bern 7
Copenhagen 7
Siena 7
Andover 6
Fontebuona 6
Medford 6
Milan 5
Barcelona 4
Changsha 4
Dearborn 4
Dong Ket 4
Helsinki 4
London 4
Salerno 4
San Diego 4
Santa Clara 4
Bologna 3
Brussels 3
Castelfiorentino 3
Ho Chi Minh City 3
Livorno 3
Los Angeles 3
Rome 3
Timisoara 3
Washington 3
Abidjan 2
Campi Bisenzio 2
Colle di Val d'Elsa 2
Easley 2
Kent 2
Moscow 2
Norwalk 2
Prato 2
Pune 2
Romola 2
Salé 2
Seoul 2
St. Catharines 2
Thiene 2
West Jordan 2
Americana 1
Amsterdam 1
Barletta 1
Bruino 1
Chiswick 1
Council Bluffs 1
Dongyang 1
Duncan 1
Falls Church 1
Frankfurt am Main 1
Genova 1
Guangzhou 1
Hanoi 1
Heze 1
Hillsboro 1
Islington 1
Jacksonville 1
Mem Martins 1
Naples 1
Phoenix 1
Redmond 1
San Miniato Basso 1
Sesto Fiorentino 1
Sestri Levante 1
Shaoxing 1
Southwark 1
Staranzano 1
Totale 1.153
Nome #
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 309
Cardiac Resynchronization Therapy for End-Stage Hypertrophic Cardiomyopathy: The Need for Disease-Specific Criteria 121
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 115
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events 115
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. 101
Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy 84
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy 83
Cardiovascular screening in low-income settings using a novel 4-lead smartphone-based electrocardiograph (D-Heart®) 82
P2316Outcome of septal reduction therapies for obstructive hypertrophic cardiomyopathy in a high-flow referral centre with moderate volume procedural programmes 61
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 60
Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy 50
Comparative analysis of a 4-lead portable smartphone-based versus standard 12-lead electrocardiograph for cardiovascular screening in low-income settings 49
Predictive value of classic sudden death risk factors in pediatric-onset hypertrophic cardiomyopathy 49
Genetic basis of pediatric sarcomeric hypertrophic cardiomyopathy: impact on long term outcome 49
Extra long term follow up of the original tuscany cohort of patients with hypertrophic cardiomyopathy 46
Cellular Retrograde Cardiomyoplasty and Relaxin Therapyfor Postischemic Myocardial Repair in a Rat Model 43
[From loss to prevention: lessons to be learned from juvenile sudden death] 39
Anti-arrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: The importance of optimal beta-blocker dose titration 36
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy] 31
Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry 31
Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring With Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy 30
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator 30
Diagnostic Delay in Arrhythmogenic Cardiomyopathy 28
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 19
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 17
The Diagnostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular Cardiomyopathy: Novel ECG Signs 2
Totale 1.680
Categoria #
all - tutte 6.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.453


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020242 0 0 4 11 29 27 40 39 33 20 29 10
2020/2021209 17 24 9 28 8 14 6 16 18 46 13 10
2021/2022134 4 9 7 8 4 6 8 10 6 11 23 38
2022/2023444 30 105 26 9 23 61 61 29 50 8 31 11
2023/2024245 5 20 31 16 25 44 18 43 8 7 12 16
2024/2025287 56 142 89 0 0 0 0 0 0 0 0 0
Totale 1.680